Colorectal Cancer Clinical Trials
Find clinical trials for colorectal cancer. Search for colorectal cancer clinical trials in different cities and states across the United States.
Dabrafenib, Trametinib, PDR001Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
Sponsor:
Massachusetts General Hospital
Location:
Code:
NCT03668431
Conditions
Metastatic Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dabrafenib
Trametinib
PDR001
TAS-OX & TAS-IRISequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Sponsor:
Rutgers, The State University of New Jersey
Location:
Code:
NCT05806931
Conditions
Colon Cancer
Rectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAS-102, oxaliplatin, irinotecan with bevacizumab
Observational StudyEarly Detection of Treatment Failure in Metastatic Colorectal Cancer Patients
Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Location:
Code:
NCT05068531
Conditions
Colorectal Cancer Metastatic
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
CRS-HIPEC vs. MelphalanComparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis
Sponsor:
University of Kansas Medical Center
Location:
Code:
NCT03073694
Conditions
Cancer, Appendiceal
ColoRectal Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Mitomycin c
Melphalan
KRAS-Targeted Vaccine, Balstilimab, BotensilimabKRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Location:
Code:
NCT06411691
Conditions
Colorectal Cancer
Pancreatic Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
KRAS Vaccine with Poly-ICLC adjuvant
Balstilimab
Botensilimab
At-Home TherapyAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients with Advanced Cancer
Sponsor:
Mayo Clinic
Location:
Code:
NCT05969860
Conditions
Advanced Anal Carcinoma
Advanced Biliary Tract Carcinoma
Advanced Bladder Carcinoma
Advanced Breast Carcinoma
Advanced Carcinoid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Clinical Encounter
Home Health Encounter
Quality-of-Life Assessment
Questionnaire Administration
LUM Imaging SystemFeasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Sponsor:
Lumicell, Inc.
Location:
Code:
NCT02584244
Conditions
Colorectal Cancer
Pancreatic Cancer
Esophageal Cancer
Gastric Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LUM015
LUM 2.6 Imaging Device
CRX100 & PembrolizumabStudy of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Sponsor:
BioEclipse Therapeutics
Location:
Code:
NCT04282044
Conditions
Solid Tumor, Adult
Triple Negative Breast Cancer
Colorectal Cancer
Hepatocellular Carcinoma
Osteosarcoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CRX100 suspension for infusion
Fludarabine
Cyclophosphamide
PF-07934040 with Anti-cancer TherapiesA Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Sponsor:
Pfizer
Location:
Code:
NCT06447662
Conditions
Carcinoma, Pancreatic Ductal
Colorectal Neoplasms
Carcinoma, Non-Small-Cell Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PF-07934040
Gemcitabine
Nab-paclitaxel
Cetuximab
Fluorouracil